Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations ALOY Q1 2024 Earnings WiderthanExpected Loss Raises Concerns Despite Stock Uptick NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline ACLS Q1 2026 Earnings EPS Misses Estimate Marginally Stock Rises 29 Auddia Inc AUUD Q1 2025 Earnings EPS Misses Estimates by a Wide Margin Amid No Revenue ZVIA Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares 136